Results 11 to 20 of about 96,199 (216)

Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients

open access: yesFrontiers in Microbiology, 2019
Highly immunocompromised pediatric and adult hematopoietic cell transplant (HCT) recipients frequently experience respiratory infections caused by viruses that are less virulent in immunocompetent individuals. Most of these infections, with the exception
Cécile Pochon   +2 more
doaj   +1 more source

KRAS RENAISSANCE(S) in Tumor Infiltrating B Cells in Pancreatic Cancer

open access: yesFrontiers in Oncology, 2018
KRAS is a driver mutation for malignant transformation. It is found in 30% of all cancers and in 90% of pancreatic cancers. The identification of small molecules selectively inhibiting KRAS mutants has been challenging, yet mutant KRAS has recently been ...
Qingda Meng   +4 more
doaj   +1 more source

The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency

open access: yesPediatric Rheumatology Online Journal, 2022
Objectives Mevalonate kinase deficiency (MKD) is a rare autoinflammatory syndrome. Several reports have described allogeneic hematopoietic stem cell transplantation in severely affected patients, sometimes with promising results.
Jerold Jeyaratnam   +11 more
doaj   +1 more source

Mycobacterium tuberculosis-specific and MHC class I-restricted CD8+ T-cells exhibit a stem cell precursor-like phenotype in patients with active pulmonary tuberculosis

open access: yesInternational Journal of Infectious Diseases, 2015
The nature and longevity of the T-cell response directed against Mycobacterium tuberculosis (MTB) are important for effective pathogen containment. We analyzed ex vivo the nature of MTB antigen-specific T-cell responses directed against the MTB secreted ...
Rebecca Axelsson-Robertson   +4 more
doaj   +1 more source

The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting

open access: yesMicroorganisms, 2023
Microbiota changes during allogeneic hematopoietic stem cell transplantation has several known causes: conditioning chemotherapy and radiation, broad-spectrum antibiotic administration, modification in nutrition status and diet, and graft-versus-host ...
Elisabetta Metafuni   +9 more
doaj   +1 more source

Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays

open access: yesInternational Journal of Infectious Diseases, 2017
Introduction: Sarcoidosis is considered an idiopathic granulomatous disease, although similar immunological and clinical features with tuberculosis (TB) suggest mycobacterial involvement in its pathogenesis.
Giovanni Ferrara   +9 more
doaj   +1 more source

Costs of allogeneic hematopoietic stem cell transplantation

open access: yesBiology of Blood and Marrow Transplantation, 2006
This study aims to determine the total costs after allogeneic hematopoietic stem cell transplantation (ASCT) and factors associated with increases or decreases in costs.We collected all in- and outpatient costs during 5 years in 93 patients who had undergone ASCT in 1998 and 1999 at our unit.
Svahn, B.-M.B.M.S.   +4 more
openaire   +2 more sources

Intra-arterial Administration of Placenta-Derived Decidual Stromal Cells to the Superior Mesenteric Artery in the Rabbit: Distribution of Cells, Feasibility, and Safety

open access: yesCell Transplantation, 2016
Selective administration of mesenchymal stromal cells to the mesenteric arteries is a potential technique to overcome pulmonary trapping and increase the density of transplanted cells in extensive mural inflammation of the intestine, such as in ...
Fabian Arnberg   +11 more
doaj   +1 more source

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

open access: yesHaematologica, 2014
Allogeneic hematopoietic stem cell transplantation is a successful treatment for hematologic malignancies and a variety of genetic and metabolic disorders.
Michael Uhlin   +9 more
doaj   +1 more source

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis [PDF]

open access: yesTherapeutic Advances in Hematology, 2020
Myelofibrosis is one of the Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms with heterogeneous clinical course. Though many treatment options, including Janus kinase (JAK) inhibitors, have provided clinical benefits and improved survival, allogeneic hematopoietic stem-cell transplantation (AHSCT) remains the only potentially curative
Lining Zhang, Fan Yang, Sizhou Feng
openaire   +3 more sources

Home - About - Disclaimer - Privacy